Skip to main content
OpenTrials
Completed

NCT Number: NCT04342208

Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak

The study aims to evaluate the working environments of individuals working from home during the covid-19 outbreak and the effect of the working environments on their musculoskeletal system.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

İstanbul University Cerrahpasa

Istanbul, Turkey (Türkiye)

About this study

The study will include people between the ages of 18-65 who work from home (works in the office before isolation) as a part of the Covid-19 isolation measure. The working environment of the individuals participating in the study will be evaluated with The Rapid Office Strain Assessment (ROSA). Musculoskeletal symptoms will be analyzed by using the Standardised Nordic Questionnaires (NMQ). Pain will be analyzed by using the Visual Analogue Scale (VAS) .

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • between the ages of 18-65
  • works from home
  • works in the office before isolation

Exclusion criteria

  • have any systemic disease that may affect on musculoskeletal system such as fibromyalgia, myofacial pain syndrome, etc.
  • have any vision problem
  • have difficulty of understanding and following online survey
  • have any physical disability
  • have self-reported computer use for less than four hours on a typical workday

Treatment and study plan

Primary outcomes

  1. The Rapid Office Strain Assessment (ROSA)

    Time frame: 30 minutes

    The working environment of the individuals participating in the study will be evaluated with The Rapid Office Strain Assessment (ROSA). ROSA is a picture-based posture checklist designed to quantify exposure to risk factors in an office work environment. In ROSA, three subsections (A-chair height, depth, armrest, and backrest; B-monitor and telephone; C-mouse and keyboard) of the office work environment are assessed. After completing the ROSA checklist, the related tables are used to calculate the score from each part, and eventually, the final ROSA score is derived. If the final score is ≤4; the risk of musculoskeletal disorders is low (low risky). If the final score is ≥5 the risk of musculoskeletal disorders risk is high (high risky).

Secondary outcomes

  1. The Standardised Nordic Questionnaries (NMQ)

    Time frame: 15 minutes

    The NMQ includes 27 items exploring the presence of musculoskeletal symptoms for the last 12 months covering nine different parts of the body. It also has items about severity grades, determined according to functional status and the presence of musculoskeletal symptoms during the 7 days. Symptoms indicate musculoskeletal disorders in different body regions among the working population. The NMQ section that questions the last 7 days will be used in the study. In that section consists additional questions relating to the neck, the shoulders, and the lower back further detail relevant issues. Twenty-five forced-choice questions elicit any accidents affecting each area, functional impact at home and work (change of job or duties), duration of the problem, assessment by a health professional, and musculoskeletal problems in the last 7 days.

Other outcomes

  1. Visual Analog Scale (VAS)

    Time frame: 2 minutes

    Pain will be analyzed by using the Visual Analogue Scale (VAS). VAS is a scale assessing pain intensity and composed of a horizontal or vertical line and anchored at both ends by words indicative of extremes of magnitude, such as "no pain" to "most intense pain sensation imaginable". In the current study, at the last 1 year and last 7 days, pain intensity was assessed by using horizontal lined VAS. Higher values show higher pain.

Sponsors and collaborators

Lead sponsor

Istanbul University - Cerrahpasa

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 10, 2020
Registry last updated
Mar 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.